WO2013147409A1 - Natural extract for preventing and treating oral disease - Google Patents

Natural extract for preventing and treating oral disease Download PDF

Info

Publication number
WO2013147409A1
WO2013147409A1 PCT/KR2013/000530 KR2013000530W WO2013147409A1 WO 2013147409 A1 WO2013147409 A1 WO 2013147409A1 KR 2013000530 W KR2013000530 W KR 2013000530W WO 2013147409 A1 WO2013147409 A1 WO 2013147409A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
content
natural
streptococcus mutans
activity
Prior art date
Application number
PCT/KR2013/000530
Other languages
French (fr)
Korean (ko)
Inventor
오명환
김원호
김근중
최형안
김윤기
Original Assignee
(주) 베리콤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주) 베리콤 filed Critical (주) 베리콤
Publication of WO2013147409A1 publication Critical patent/WO2013147409A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • A61K36/03Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/902Sparganiaceae (Bur-reed family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063Periodont
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Definitions

  • the present invention relates to extracts having the activity for the prevention and treatment of oral diseases isolated from natural materials, more specifically, at least 50% growth inhibitory activity and at least 50% active oxygen against Streptococcus mutans. It is directed to a natural extract characterized by simultaneously exhibiting species inhibitory activity.
  • Saliva and secretions in the oral cavity contain a variety of proteins.
  • saliva containing an enzyme called Lysozyme is continuously secreted in the mouth to control microorganisms, but the nutrient-rich oral environment is optimal for microbial growth. It can be a condition, but it does not induce complete death.
  • the oral tongue and dental plaque are used as a refuge for pathogenic microorganisms.
  • Dental caries is caused by microorganisms that form plaque (dental plaque), which undergo fermentation metabolism using nutrients in the mouth to produce various organic acids such as lactic acid and remove calcium from the tooth surface.
  • the plaque is formed by a protein in the saliva forming a thin film on the teeth, the Streptococcus sobrinus ( Streptococcus sobrinus ), and Streptococcus mutans ( Streptococcus mutans ), a kind of Streptococcus It is made by forming a biofilm and is further thickened by Fuscobacterium.
  • Periodontal disease is a disease that causes inflammation and loss of structure of the periodontal tissue, also called the appearance. Specifically, periodontal disease is a disease in which tissues around the teeth holding the teeth are inflamed, and are clinically caused by gingival bleeding, swelling, periodontal pockets, and destruction of the alveolar bone. This results in loss of teeth.
  • the main cause of periodontal disease is plaque.
  • the plaque When the plaque is mechanically accumulated in the periodontal sac, it becomes a habitat for bacteria present in the periphery, and the habitat gradually migrates into aerobic, breathable and Gram-positive bacteria, and proliferates deep into the periodontal sac. Will be.
  • toxins and all products of anaerobic gram-negative bacteria proliferated together directly destroy tissues or stimulate the immune system, causing inflammation along with periodontal tissue destruction by various actions from the stimulated immune system.
  • periodontal disease is an inflammatory disease that causes tissue damage as a result of complex interactions between the bacteria and the host's immune response.
  • oxygen species ROS
  • Host cells and bacteria have an antioxidant defense system that eliminates damage caused by reactive oxygen species.
  • the main extracellular antioxidants located in saliva, gingival crevicular fruid or plasma are ascorbic acid (vitamin C), uric acid, ⁇ -tocopherol (vitamin E), Carotenoids (vitamin A), bilirubin, bilirubin, reduced glutathione, transferrin, lactoferrin, haptoglobin, and the like.
  • Herbal extracts exhibiting antimicrobial activity against S. mutans include digging, grapefruit seeds, missing seeds, Angelica, cinnamon, propolis, seaweed, cocoa polyphenols, flavonoids, and palms. Cactus and the like are known.
  • many polyphenols have been isolated from tea extracts such as green tea, black tea and oolong tea, which are known to partially inhibit the production of biofilm-forming substances emitted by caries.
  • herbal extracts for preventing or treating periodontal disease include myrrha, raw white skin extract, lettuce extract, corn extract, thick extract, ginkgo leaf extract, jujube extract, milky white extract, rye extract, ginger extract, Toxic extracts are known.
  • the conventional natural extracts exhibit only antibacterial activity or only antioxidant activity, so there is a problem that they can be used only for the prevention and treatment of some diseases of oral diseases.
  • the present invention in order to solve the problems of the prior art as described above and the technical problem that has been requested from the past, oral disease-inducing strain Streptococcus mutans (streptococcus mutans) of It is an object of the present invention to provide a natural extract having both growth inhibitory activity and active oxygen species inhibitory activity, which is a factor causing periodontal disease.
  • the natural extract according to the present invention is an extract having the activity for preventing and treating oral diseases isolated from natural materials, and has at least 50% growth inhibitory activity and at least 50% active oxygen against Streptococcus mutans. It is characterized by simultaneously displaying species inhibitory activity.
  • the 50% growth inhibitory activity and 50% reactive oxygen species inhibitory activity is the minimum concentration for the effectiveness of antimicrobial agents for the prevention and treatment of oral diseases, that is, the antimicrobial activity. When more than 50% bacterial growth inhibition is confirmed, it is considered to have antimicrobial activity.
  • the natural extract may be isolated from natural materials selected from the group consisting of cypress, black samreung and persimmon.
  • the Thuja orientalis L. is an evergreen coniferous tree belonging to the genus Cypressaceae, reaching 25m in height and 1m in diameter, but belongs to shrubs, and small branches grow vertically. It is called.
  • leaves and fruits are used as medicinal herbs, and the weakness of the leaves is mild and sour. Used.
  • Fruit is weak and flat, and it has the effect of nourishing, calming, and ringing. It is a treatment for nervous breakdown, insomnia, palpitations, physical weakness, and constipation. Used.
  • the black samreung (Sparganium stoloniferum) is a perennial herb of the black samreung and grows in ponds and ditches, with stems extending laterally and stems coming from various places. Roots and stems are used as sojong, tong economy, and choije.
  • Samneung ( ⁇ ) a Korean herb that has dried roots of black samreung, has no fragrance and a mild taste, but when chewed, it is slightly stinged and has an arine taste.
  • Samneung protects qi to strengthen the flow of qi and eliminates blood, so it is used for postpartum blood cramps, dysmenorrhea, dysmenorrhea, dysmenorrhea, jinga, and harvesting. It also removes food that is difficult to digest food. .
  • Pharmacological effects on ectopic pregnancy effects on primary liver cancer, malignant tumors, gastric cancer, liver cancer, esophageal cancer, cervical cancer, mammary gland cancer, rectal cancer, lung cancer, etc. It is known that it has been shown to have an effect on improving cardiopathy and around the appendix of coronary artery disease.
  • the persimmon tree is a deciduous tree belonging to the camphor tree growing in the sunny place of the foot of the mountain and is also called ganja or white camellia.
  • Korean Herb Book "Sanchocho is the fruit of the camphor tree Lindera glauca Blume. The taste is spicy, warm in nature, and the effect is paralyzed, and it is used for cold-boiled cold. Suddenly speaking due to a stroke, you can put it in water and take it for months. Is written. Therefore, it is used in folk medicine for the treatment of tingling, paralysis, arthralgia and muscle pain due to customs, treatment of cardiac cold pain, traumatic bleeding, cold, headache, bleeding, and swelling.
  • the natural material may be a leaf, fruit or stem of the cypress tree, may be an outpost of the Black Samreung, may be a stem or leaf of Ecklonia chinensis.
  • the content of the leaf, fruit or stem extract of the cypress tree to have at least 50% growth inhibitory activity against Streptococcus mutans is at least 500 ⁇ g / ml.
  • the content of the black samreung outpost extract to have at least 50% growth inhibitory activity against Streptococcus mutans is at least 100 ⁇ g / ml.
  • the content of the stem or leaf extract of the persimmon tree to have at least 50% growth inhibitory activity against Streptococcus mutans is at least 100 ⁇ g / ml.
  • the polyphenol content of the leaves, berries, or stems of the cypress which exhibited more than 50% of active oxygen species inhibition activity, was measured in mg per 100 g of dry sample using the calibration curve by gallic acid (mg GAE / 100g dw). ) Is 395.27 ⁇ 24.39 mg GAE / 100g dw, and the flavonoid content is 250.14 ⁇ 18.26 mg when calculated as mg content (mg RE / 100g dw) per 100 g of dry sample using the calibration curve by rutin.
  • the content of leaf, fruit or stem extract of the cypress which exhibits 50% DPPH (2,2-diphenyl-2-picrylhydrazyl hydrate) radical scavenging activity, is 33.10 ⁇ 3.67 ⁇ g / ml or more.
  • the content of the leaf, fruit or stem extract of the cypress, showing% ABTS (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) radical scavenging activity is 62.96 ⁇ 5.23 ⁇ g / ml or more.
  • the polyphenol content of the black samreung outpost showing 50% or more active oxygen species inhibition activity was calculated as mg content (mg GAE / 100g dw) per 100g of dry sample using the calibration curve by gallic acid.
  • ⁇ 13.57mg GAE / 100g dw and flavonoid content is 61.01 ⁇ 3.62 mg rutin / 100g dw or more calculated as mg content per 100g of dry sample (mg RE / 100g dw) using calibration curve by rutin
  • the content of Black Samreung Outpost extract showing 50% DPPH radical scavenging activity is 166.30 ⁇ 5.94 ⁇ g / ml or more
  • the content of Black Samneung Outpost extract showing 50% ABTS radical scavenging activity is 155.76 ⁇ 9.05 ⁇ g / ml or more.
  • the polyphenol content of the stem or leaves of E. coli showing 50% or more active oxygen species inhibition activity was obtained in mg content (mg GAE / 100g dw) per 100g of dry sample using the calibration curve by gallic acid. When calculated, it is 189.70 ⁇ 4.33 mg GAE / 100g, and the flavonoid content is 67.50 ⁇ 1.45 mg RE / 100g dw when the mg content per 100g of dry sample (mg RE / 100g dw) is calculated using the calibration curve by rutin. In this case , the extract content of E.
  • coli stem or leaf exhibiting 50% DPPH radical scavenging activity is 28.45 ⁇ 3.96 ⁇ g / ml or more, and the extract content of stem or leaf of E. coli showing 50% ABTS radical scavenging activity 34.52 ⁇ 0.34 ⁇ g / ml or more.
  • the natural extract according to the present invention can be prepared by heating the natural material described above in water or alcohol to obtain an extract and concentrating the extract.
  • 150 g of dried natural cypress material is put into an extraction bottle and poured distilled water and extracted three times at a temperature of 80 to 121 ° C. for 5 hours, or 150 g of dried natural material is 95 to 99% ethanol.
  • the mixture is heated in methanol at a volume of 1 to 15 times and heated at 70 to 80 ° C. for 12 hours in an extractor equipped with a cooling capacitor.
  • the extracted extract is filtered under reduced pressure, and the solids are removed and the filtrate is concentrated with a cooling capacitor.
  • Preferred in the present invention may be prepared by concentrating under reduced pressure to 50 to 90 brix and then freeze drying.
  • the natural extract is an active ingredient for preventing and treating oral diseases, and can be used as a medicine regardless of the dosage form, and non-limiting examples include liquid toothpaste, mouthwash, mouth spray, oral ointment, oral varnish, and the like. It can be used in the form.
  • 1 is a graph showing 50% growth inhibitory activity concentration determination of Streptococcus mutans of the extracts of the cedar, black samreung, and persimmon tree extracted according to the embodiment of the present invention.
  • Example 1 Using the natural extract prepared in Example 1 was carried out experiments to determine the growth inhibition activity of the caries disease-causing bacteria, growth inhibitory activity concentration for the caries disease-causing bacteria. Efficacy determination was determined as the minimum concentration concentration showing a growth inhibitory effect of more than 50%. This is the minimum growth inhibitory activity concentration of bacteria for use in prophylactic and therapeutic purposes.
  • Streptococcus mutans an oral disease-causing bacterium, as an experimental bacterium (Streptococcus mutans) was sold as a frozen vial from the Korean Collection for Type Cultures (KCTC) Streptococcus mutans KCTC3065 was used.
  • KCTC Korean Collection for Type Cultures
  • Streptococcus mutans was inoculated in brain heart infusion medium (Sheep brain and heart extract 37%) and incubated for 20 to 24 hours at 37 °C, aerobic conditions.
  • brain heart infusion medium Sheep brain and heart extract 37%)
  • 50% growth inhibitory activity concentration ( ⁇ g / ml) of each natural oral disease-inducing bacterium natural extracts were added to the liquid medium, and 0 to 500 ⁇ g / ml through the serial dilution method. Diluted to a range of concentrations and sterilized.
  • each of the bacteria pre-cultured in the medium added by the concentration of each natural extract was inoculated to 2 ⁇ 10 6 cells / ml in the spectrophotometer OD 600nm and incubated under the growth conditions of each bacteria.
  • the extract of each natural material obtained as described above may vary in efficacy depending on the growth environment of the plant, such as when the plant is collected, the place of habitation.
  • Polyphenols have an antioxidant effect and are known as major substances applied to foods and medicine.
  • 100 ⁇ l of 10% Na 2 CO 3 was added to 100 ⁇ l of the natural extract 1 mg / ml according to the present invention and allowed to stand at room temperature for 5 minutes.
  • the content of the ingredient was expressed in mg content per 100g of dry sample using calibration curves prepared from gallic acid and rutin, which are standard samples according to the recommendations of the Food and Drug Administration. The results are shown in Table 2 below.
  • the total polyphenol and total flavonoid content of the extract according to the present invention was confirmed to have the highest content in the cypress.
  • As an antioxidant it was found that the cypress extract is more preferable than the black samreung extract and the persimmon tree extract.
  • the experimental results were expressed as mean ⁇ standard deviation after three repeated measurements. The significance between the sample groups was verified and analyzed according to Duncan's multiple range test at p ⁇ 0.05.
  • the extract of each natural material obtained as described above may vary in efficacy depending on the growth environment of the plant, such as when the plant is collected, the place of habitation.
  • DPPH antioxidant activity test and ABTS antioxidant activity test were performed to determine the free radical scavenging activity to determine the inhibitory effect of active oxygen species.
  • DPPH radical scavenging activity was measured by mixing 60 ⁇ l of 0.2 mM DPPH (2,2-diphenyl-2-picrylhydrazyl hydrate) and 60 ⁇ l of the sample prepared for each concentration, and reacting in a dark room at room temperature for 15 to 30 minutes using a spectrophotometer. Absorbance was measured at.
  • Nitrite scavenging activity was performed by Kato et al. (Ref. Kato H, Lee IE 1987). 40 ⁇ l of 1 mM NaNO 2 is added to 40 ⁇ l natural extract. After calibrating to pH 1.2 using 0.1 N HCl, the reaction was carried out at 37 ° C. for 1 hour. After adding 1 ml of 2% acetic acid and 100 ⁇ l of Griess reagent, the reaction was performed at room temperature for 15 minutes and the absorbance was measured at 520 nm. The results are shown in Table 3 below.
  • vitamin C ascorbic acid
  • the scavenging activity of the control group, vitamin C was 96.64 ⁇ 0.26%.
  • the antioxidant efficacy measurement experiment using the DPPH and ABTS according to the present invention was able to confirm the excellent antioxidant effect in the cypress and Ecklonia cava, the nitrite scavenging activity was excellent in the cypress.
  • the extract used in the group consisting of the natural product of the natural material according to the present invention, the cedar, black samreung and persimmon tree is 50% growth inhibitory activity against Streptococcus mutans (Streptococcus mutans) At the same time, it exhibited 50% of active oxygen species inhibitory activity, in particular, the cypress had a desirable antioxidant effect.
  • the experimental results were expressed as mean ⁇ standard deviation after three repeated measurements. The significance between the sample groups was verified and analyzed according to Duncan's multiple range test at p ⁇ 0.05.
  • the natural extract according to the present invention simultaneously exhibits at least 50% growth inhibitory activity and at least 50% active oxygen species inhibitory activity against Streptococcus mutans , an oral disease causing strain at a predetermined concentration.
  • medicines containing this as an active ingredient have the advantage of preventing and treating dental caries and periodontal disease at the same time.
  • the natural extract according to the present invention when used as a toothpaste, oral cleaning agent, etc., the growth of Streptococcus mutans is suppressed by 50% or more, which has the advantage of efficiently removing plaque that is a bacterial precipitate. have.

Abstract

The present invention relates to an extract having the activity of preventing and treating oral disease, wherein the extract is isolated from natural substances. The natural extract is characterized in that is shows growth inhibition activity of 50% or more and reactive oxygen species inhibition activity of 50% or more with respect to Streptococcus mutans.

Description

구강질환 예방 및 치료용 천연 추출물 Natural extracts for the prevention and treatment of oral diseases
본 발명은 천연물 소재로부터 분리한 구강질환 예방 및 치료용 활성을 가진 추출물에 관한 것으로서, 더욱 상세하게는, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 50% 이상의 생장억제 활성과 50% 이상의 활성 산소종 억제 활성을 동시에 나타내는 것을 특징으로 하는 천연 추출물에 대한 것이다.The present invention relates to extracts having the activity for the prevention and treatment of oral diseases isolated from natural materials, more specifically, at least 50% growth inhibitory activity and at least 50% active oxygen against Streptococcus mutans. It is directed to a natural extract characterized by simultaneously exhibiting species inhibitory activity.
사람의 입안(구강)에는 다양한 종류의 세균들이 군집을 형성하고 있다. 구강의 타액과 분비물에는 다양한 단백질이 존재하는데, 예를 들어 입안에는 라이소자임(Lysozyme)이라는 효소를 포함하고 있는 침이 지속적으로 분비되어 미생물을 제어하고 있지만, 영양분이 가득한 구강환경은 미생물 성장에 최적의 조건이 될 수 있기에 완전한 사멸을 유도하지는 못한다. 특히 구강의 혀나 치태(dental plaque)는 병원성 미생물들의 도피처로 이용되고 있다. Various kinds of bacteria form a colony in the mouth of a person. Saliva and secretions in the oral cavity contain a variety of proteins.For example, saliva containing an enzyme called Lysozyme is continuously secreted in the mouth to control microorganisms, but the nutrient-rich oral environment is optimal for microbial growth. It can be a condition, but it does not induce complete death. In particular, the oral tongue and dental plaque are used as a refuge for pathogenic microorganisms.
사람의 구강(oral cavity) 내에 생존하는 것으로 추측되는 미생물은 대략 600 내지 800종 이상으로 알려져 있고, 이 중 박테리아(bacteria)가 대부분을 차지하고 있지만, 고세균(archaea)이나 진핵미생물(fungi and yeast)도 많이 포함되어 있는 것으로 알려져 있다. About 600 to 800 species of microorganisms are believed to survive in the oral cavity of humans, and most of them are bacteria, but archae and fungi and yeast are also known. It is known to contain a lot.
이들 중 대부분은 무해한 일반세균이거나, 이들과 공생관계에 있는 미생물이지만, 일부의 미생물들은 기회 병원균(opportunistic pathogen)으로서, 치아우식증(dental cavities; 충치)과 치주질환(periodontal disease; 풍치)와 같은 질환의 원인이 된다. Most of them are harmless common bacteria or microorganisms that are symbiotic with them, but some of them are opportunistic pathogens, such as dental cavities and periodontal disease. Cause.
치아우식증은, 플라크(dental plaque; 치태)를 형성하는 미생물들이 입 속의 영양분을 이용해 발효대사를 진행하여 젖산과 같은 다양한 유기산을 만들고 치아표면의 칼슘을 제거함으로써 유발된다. 상기 플라크는, 침 속에 있는 단백질이 치아에 얇은 막을 형성하고, 그 위에 연쇄상구균의 일종인 스트렙토코쿠스 소브리누스(Streptococcus sobrinus)균 및 스트렙토코쿠스 뮤탄스(Streptococcus mutans)가 순서대로 부착해 바이오 필름(biofilm)을 형성함으로써 만들어지고, 푸조박테리움(Fusobacterium)에 의해 더욱 두꺼워진다.Dental caries is caused by microorganisms that form plaque (dental plaque), which undergo fermentation metabolism using nutrients in the mouth to produce various organic acids such as lactic acid and remove calcium from the tooth surface. The plaque is formed by a protein in the saliva forming a thin film on the teeth, the Streptococcus sobrinus ( Streptococcus sobrinus ), and Streptococcus mutans ( Streptococcus mutans ), a kind of Streptococcus It is made by forming a biofilm and is further thickened by Fuscobacterium.
일단 치아표면 에나멜층이 유기산에 의해 파괴되면 그 아래의 치아층도 미생물이 분비한 단백질 분해효소에 의해 파괴되고 결국 치아우식증이 심해진다 Once the tooth surface enamel layer is destroyed by organic acids, the tooth layer below it is also destroyed by the protease secreted by microorganisms, which in turn causes severe dental caries.
치주질환은 치주조직의 염증과 구조의 소실을 야기시키는 질환으로서, 풍치라고도 불린다. 구체적으로, 치주질환은 치아를 떠받들고 있는 치아주위의 조직에 염증이 생기는 질환으로서, 임상적으로 치은출혈(gingival bleeding)과 종창(swelling), 치주낭(periodontal pocket)의 형성 및 치조골의 파괴 등으로 치아의 상실을 가져오게 된다. Periodontal disease is a disease that causes inflammation and loss of structure of the periodontal tissue, also called the appearance. Specifically, periodontal disease is a disease in which tissues around the teeth holding the teeth are inflamed, and are clinically caused by gingival bleeding, swelling, periodontal pockets, and destruction of the alveolar bone. This results in loss of teeth.
이러한 치주질환의 주요 원인은 플라크로서, 이러한 플라크가 치주낭 내에 기계적으로 축적되면 주변에 존재하는 세균들의 서식처가 되며, 이러한 서식은 점차 호기성, 통기성, 그람 양성세균으로 점차 이행되어, 치주낭의 심부로 증식되게 된다. 이때 함께 증식된 혐기성 그람음성 세균의 독소 및 모든 산물은 직접 조직을 파괴하거나 면역계를 자극하여, 자극된 면역계에서부터 여러가지 작용에 의한 치주조직 파괴와 더불어 염증을 유발하게 된다. The main cause of periodontal disease is plaque. When the plaque is mechanically accumulated in the periodontal sac, it becomes a habitat for bacteria present in the periphery, and the habitat gradually migrates into aerobic, breathable and Gram-positive bacteria, and proliferates deep into the periodontal sac. Will be. At this time, toxins and all products of anaerobic gram-negative bacteria proliferated together directly destroy tissues or stimulate the immune system, causing inflammation along with periodontal tissue destruction by various actions from the stimulated immune system.
최근 연구보고에 의하면, 치주질환은 세균과 숙주(host)간 면역반응의 복잡한 상호작용의 결과로 조직손상이 야기되는 염증성 질환으로, 세균과 숙주에 의해 조절되는 조직 손상 경로에 활성 산소종(reactive oxygen species, ROS)도 관여하는 것으로 보고되고 있다. According to a recent study, periodontal disease is an inflammatory disease that causes tissue damage as a result of complex interactions between the bacteria and the host's immune response. oxygen species (ROS) are also reported to be involved.
숙주세포와 세균들은 활성 산소종에 의한 손상에 대한 방어기능으로서, 이를 제거하기 위한 항산화 방어체계를 갖추고 있다. Host cells and bacteria have an antioxidant defense system that eliminates damage caused by reactive oxygen species.
타액, 치은열구액(gingival crevicular fruid) 또는 혈장 내에 위치해 있는 주요한 세포외항산화제로는 아스코르빈산(ascorbic acid; Vitamin C), 요산(uric acid), α-토코페롤(α-tocopherol; Vitamin E), 카로티노이드(carotenoids; Vitamin A), 빌리루빈(bilirubin), 환원형 글루타치온(reduced glutathione), 트랜스페린 (transferrin), 락토페린(lactoferrin), 합토글라빈(haptoglobin) 등이 있다. The main extracellular antioxidants located in saliva, gingival crevicular fruid or plasma are ascorbic acid (vitamin C), uric acid, α-tocopherol (vitamin E), Carotenoids (vitamin A), bilirubin, bilirubin, reduced glutathione, transferrin, lactoferrin, haptoglobin, and the like.
최근에는 치아우식증을 예방하기 위해서 구강내 세균을 효과적으로 제거하면서 부작용 없이 안전하게 사용할 수 있는 생약추출물에 관한 연구가 활발하게 이루어지고 있는데, 이는 생약제제들이 이미 민간에서 다양한 목적으로 오래 전부터 사용되어 상대적으로 생체에 대한 안정성이 검증되었기 때문이다. Recently, research has been actively conducted on herbal extracts that can be safely used without side effects while effectively removing oral bacteria in order to prevent dental caries. This is because the stability of is verified.
치아우식증의 주원인균인 스트렙토코쿠스 뮤탄스(S. mutans)에 대한 항균 작용을 나타내는 생약 추출물질로는 파고자, 자몽씨, 결명자, 당귀, 계피, 프로폴리스, 해조류, 코코아 폴리페놀, 플라보노이드, 손바닥 선인장 등이 알려져 있다. 또한 녹차, 홍차, 우롱차와 같은 차 추출물로부터 많은 폴리페놀이 분리되었으며, 이는 충치균이 방출하는 바이오필름 형성물질의 생성을 부분적으로 억제한다고 알려져 있다.Herbal extracts exhibiting antimicrobial activity against S. mutans , the main cause of dental caries, include digging, grapefruit seeds, missing seeds, Angelica, cinnamon, propolis, seaweed, cocoa polyphenols, flavonoids, and palms. Cactus and the like are known. In addition, many polyphenols have been isolated from tea extracts such as green tea, black tea and oolong tea, which are known to partially inhibit the production of biofilm-forming substances emitted by caries.
또한, 치주질환을 예방 또는 치료하기 위한 생약추출물은 몰약(Myrrha), 생백피 추출물, 상귀나리아 추출물, 옥수수의 추출물, 후박추출물, 은행잎 추출물, 대추추출물, 유백피추출물, 황련추출물, 생강추출물, 독활추출물 등이 알려져 있다. In addition, herbal extracts for preventing or treating periodontal disease include myrrha, raw white skin extract, lettuce extract, corn extract, thick extract, ginkgo leaf extract, jujube extract, milky white extract, rye extract, ginger extract, Toxic extracts are known.
그러나, 종래의 천연추출물은 항균성만을 발휘하거나 또는 항산화 활성만을 발휘하므로, 구강질환 중 일부 질환의 예방 및 치료에만 국한되어 사용될 수 밖에 없는 문제가 있었다. However, the conventional natural extracts exhibit only antibacterial activity or only antioxidant activity, so there is a problem that they can be used only for the prevention and treatment of some diseases of oral diseases.
따라서, 구강질환 균과 치주질환 유발 활성 산소종에 대해 억제활성을 지닌 천연물 소재에 대한 필요성이 높은 실정이다. Therefore, there is a high need for a natural material having inhibitory activity against oral disease bacteria and periodontal disease-inducing reactive oxygen species.
본 발명은 상기와 같은 종래기술의 문제점과 과거로부터 요청되어온 기술적 과제를 해결하기 위해서, 구강질환 유발균주인 스트렙토코쿠스 뮤탄스(streptococcus mutans) 생장억제 활성과 치주질환 유발인자인 활성 산소종 억제 활성을 동시에 갖는 천연 추출물을 제공하는 것을 목적으로 한다. The present invention, in order to solve the problems of the prior art as described above and the technical problem that has been requested from the past, oral disease-inducing strain Streptococcus mutans(streptococcus mutans)of It is an object of the present invention to provide a natural extract having both growth inhibitory activity and active oxygen species inhibitory activity, which is a factor causing periodontal disease.
따라서, 본 발명에 따른 천연 추출물은, 천연물 소재로부터 분리한 구강질환 예방 및 치료용 활성을 가진 추출물로서, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 50% 이상의 생장억제 활성과 50% 이상의 활성 산소종 억제 활성을 동시에 나타내는 것을 특징으로 한다. Therefore, the natural extract according to the present invention is an extract having the activity for preventing and treating oral diseases isolated from natural materials, and has at least 50% growth inhibitory activity and at least 50% active oxygen against Streptococcus mutans. It is characterized by simultaneously displaying species inhibitory activity.
상기 50% 의 생장억제 활성과 50% 의 활성 산소종 억제 활성은 구강질환 예방 및 치료용 항균물질의 유효성, 즉, 항균성 판단을 위한 최소 농도로서, 식물추출물의 경우, 단일물질이 아닌 혼합물질로써 50% 이상의 세균 성장억제력이 확인될 때 항균성이 있는 것으로 판단한다. The 50% growth inhibitory activity and 50% reactive oxygen species inhibitory activity is the minimum concentration for the effectiveness of antimicrobial agents for the prevention and treatment of oral diseases, that is, the antimicrobial activity. When more than 50% bacterial growth inhibition is confirmed, it is considered to have antimicrobial activity.
상기 천연 추출물은 측백나무, 흑삼릉 및 감태나무로 이루어진 군에서 선택되는 천연물 소재로부터 분리된 것일 수 있다. The natural extract may be isolated from natural materials selected from the group consisting of cypress, black samreung and persimmon.
상기 측백나무(Thuja orientalis L.)는 측백나무과에 속하는 상록침엽교목으로서 높이 25m, 지름 1m에 달하지만 관목상에 속하며, 작은 가지가 수직으로 벌어지는데, 이와 같이 가지가 수직으로 발달하므로 측백이라는 이름으로 불린다. 한방에서는 잎과 열매를 약재로 사용하는데, 잎의 약성은 양하고 신미고(辛微苦)하며, 지혈, 양혈, 수렴, 이뇨의 작용을 하여 토혈, 혈변, 대장염, 이질, 고혈압 등의 증상에 사용된다. 열매는 약성이 감(甘)하고 평(平)하며, 자양(滋養), 진정, 윤장(潤腸)의 효능이 있어 신경쇠약, 불면, 심계항진(心悸亢進), 신체허약, 변비 등의 치료제로 쓰인다.The Thuja orientalis L. is an evergreen coniferous tree belonging to the genus Cypressaceae, reaching 25m in height and 1m in diameter, but belongs to shrubs, and small branches grow vertically. It is called. In oriental medicine, leaves and fruits are used as medicinal herbs, and the weakness of the leaves is mild and sour. Used. Fruit is weak and flat, and it has the effect of nourishing, calming, and ringing. It is a treatment for nervous breakdown, insomnia, palpitations, physical weakness, and constipation. Used.
또한, 흑삼릉(Sparganium stoloniferum)은 흑삼릉과의 여러살이풀로서, 연못가와 도랑에서 자라는데, 뿌리줄기가 옆으로 뻗으며 군데군데에서 줄기가 나온다. 뿌리, 줄기는 소종, 통경제, 최유제로 사용하는데, 흑삼릉의 덩이뿌리를 말린 한국약재인 삼릉(三稜)은 향이 없고 담담한 맛이지만 씹으면 약간 쏘며 아린 맛이 있다. 삼릉은 기를 보호하여 기의 흐름을 강하게 해주고 어혈을 없애는 작용이 있어 산후 어혈복통, 월경부조, 월경통, 월경폐색불통, 징가, 적취 등에 사용되며, 음식의 소화가 잘 안되는 식적을 제거시키는 작용도 있다. 약리작용으로 자궁외임신에 대한 유효성, 악성종양인 원발성간암에 대한 효과, 위암, 간암, 식도암, 자궁경부암, 유선암, 직장암, 폐암 등의 호전반응, 뇌혈전, 뇌전색, 뇌일혈로 인한 반신불수에 유효성을 보였고, 관상동맥질환의 심교통증 개선작용, 충수돌기 주위에도 효력을 나타냈다는 것이 알려져 있다.In addition, the black samreung (Sparganium stoloniferum) is a perennial herb of the black samreung and grows in ponds and ditches, with stems extending laterally and stems coming from various places. Roots and stems are used as sojong, tong economy, and choije. Samneung (三稜), a Korean herb that has dried roots of black samreung, has no fragrance and a mild taste, but when chewed, it is slightly stinged and has an arine taste. Samneung protects qi to strengthen the flow of qi and eliminates blood, so it is used for postpartum blood cramps, dysmenorrhea, dysmenorrhea, dysmenorrhea, jinga, and harvesting. It also removes food that is difficult to digest food. . Pharmacological effects on ectopic pregnancy, effects on primary liver cancer, malignant tumors, gastric cancer, liver cancer, esophageal cancer, cervical cancer, mammary gland cancer, rectal cancer, lung cancer, etc. It is known that it has been shown to have an effect on improving cardiopathy and around the appendix of coronary artery disease.
또한, 상기 감태나무는 산기슭의 양지에 자라는 녹나무과에 속하는 낙옆관목으로 간자목 또는 백동백이라고도 한다. 한국본초도감에 의하면, "산호초(山胡椒)는 녹나무과의 갈잎떨기나무 감태나무(Lindera glauca Blume)의 열매이다. 맛은 맵고 성질은 따뜻하며, 효능은 중풍으로 말 못하는데 및 심복냉통에 사용한다. 중풍으로 갑자기 말을 못하는 증상에는 물에 넣고 달여서 복용하고 복부가 차서 일어나는 통증을 해소시킨다." 라고 기록되어 있다. 따라서, 민간에서는 풍습으로 인한 저림증, 마비, 관절통 및 근육통의 치료, 심복냉통의 치료, 외상출혈, 감기, 두통, 발혈, 악창 종독의 치료에 사용된다. In addition, the persimmon tree is a deciduous tree belonging to the camphor tree growing in the sunny place of the foot of the mountain and is also called ganja or white camellia. According to the Korean Herb Book, "Sanchocho is the fruit of the camphor tree Lindera glauca Blume. The taste is spicy, warm in nature, and the effect is paralyzed, and it is used for cold-boiled cold. Suddenly speaking due to a stroke, you can put it in water and take it for months. Is written. Therefore, it is used in folk medicine for the treatment of tingling, paralysis, arthralgia and muscle pain due to customs, treatment of cardiac cold pain, traumatic bleeding, cold, headache, bleeding, and swelling.
이와 같이, 측백나무, 흑삼릉 및 감태나무의 잎, 열매 등의 천연물 소재들은 다양한 약리활성이 보고되어 있지만, 아직까지 구강질환 유발균주에 대한 항균성과 치주질환 유발요소인 활성 산소종에 대한 항산화 효능을 동시에 가지는 약리활성에 대한 보고와 연구는 전무한 상태이다. As such, natural medicinal materials such as leaves and berries of the cypress, black samreung and persimmon trees have been reported to have various pharmacological activities. At the same time, there are no reports and studies of pharmacological activity.
상기 천연물 소재는 측백나무의 잎, 열매 또는 줄기일 수 있고, 흑삼릉의 전초일 수 있으며, 감태나무의 줄기 또는 잎일 수 있다. The natural material may be a leaf, fruit or stem of the cypress tree, may be an outpost of the Black Samreung, may be a stem or leaf of Ecklonia chinensis.
스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대한 50% 이상의 생장억제 활성을 갖기 위한 측백나무의 잎, 열매 또는 줄기 추출물의 함량은, 최소 500 ㎍/㎖ 이상이다.The content of the leaf, fruit or stem extract of the cypress tree to have at least 50% growth inhibitory activity against Streptococcus mutans is at least 500 μg / ml.
또한, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대한 50% 이상의 생장억제 활성을 갖기 위한 흑삼릉 전초 추출물의 함량은, 최소 100 ㎍/㎖ 이상이다.In addition, the content of the black samreung outpost extract to have at least 50% growth inhibitory activity against Streptococcus mutans is at least 100 μg / ml.
또한, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대한 50% 이상의 생장억제 활성을 갖기 위한 감태나무의 줄기 또는 잎 추출물의 함량은, 최소 100 ㎍/㎖ 이상이다.In addition, the content of the stem or leaf extract of the persimmon tree to have at least 50% growth inhibitory activity against Streptococcus mutans is at least 100 μg / ml.
또한, 50% 이상의 활성 산소종 억제 활성을 나타내는 측백나무의 잎, 열매 또는 줄기의 폴리페놀 함량이, 갈산(gallic acid)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg GAE/100g dw)으로 계산할 때, 395.27±24.39 mg GAE/100g dw 이고, 플라보노이드 함량이, 루틴(rutin)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg RE/100g dw)으로 계산하면 250.14±18.26 mg rutin/100g dw 이상일때, 50%의 DPPH(2,2-diphenyl-2-picrylhydrazyl hydrate) 라디칼 소거 활성을 나타내는 측백나무의 잎, 열매 또는 줄기 추출물의 함량은 33.10 ± 3.67 ㎍/㎖ 이상 이며, 50%의 ABTS(2,2`-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) 라디칼 소거 활성을 나타내는 측백나무의 잎, 열매 또는 줄기 추출물의 함량은 62.96±5.23 ㎍/㎖ 이상이다. In addition, the polyphenol content of the leaves, berries, or stems of the cypress, which exhibited more than 50% of active oxygen species inhibition activity, was measured in mg per 100 g of dry sample using the calibration curve by gallic acid (mg GAE / 100g dw). ) Is 395.27 ± 24.39 mg GAE / 100g dw, and the flavonoid content is 250.14 ± 18.26 mg when calculated as mg content (mg RE / 100g dw) per 100 g of dry sample using the calibration curve by rutin. When rutin / 100g dw or more, the content of leaf, fruit or stem extract of the cypress, which exhibits 50% DPPH (2,2-diphenyl-2-picrylhydrazyl hydrate) radical scavenging activity, is 33.10 ± 3.67 ㎍ / ml or more. The content of the leaf, fruit or stem extract of the cypress, showing% ABTS (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) radical scavenging activity is 62.96 ± 5.23 μg / ml or more.
이 때, 측백나무 잎, 열매 및 줄기 추출물 1㎎/㎖은 90.44±1.18%의 치주질환 염증에 의해 생성되는 아질산염(nitrite) 소거활성을 나타낸다. At this time, 1 mg / ㎖ of the cypress leaf, fruit and stem extract exhibits nitrite scavenging activity produced by the periodontal disease inflammation of 90.44 ± 1.18%.
또한, 50% 이상의 활성 산소종 억제 활성을 나타내는 흑삼릉 전초의 폴리페놀 함량이, 갈산(gallic acid)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg GAE/100g dw)으로 계산할 때, 151.62±13.57mg GAE/100g dw 이고, 플라보노이드 함량이, 루틴(rutin)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg RE/100g dw)으로 계산하면 61.01±3.62 mg rutin/100g dw 이상일때, 50%의 DPPH 라디칼 소거 활성을 나타내는 흑삼릉 전초 추출물의 함량은 166.30±5.94 ㎍/㎖ 이상이며, 50%의 ABTS 라디칼 소거 활성을 나타내는 흑삼릉 전초 추출물의 함량은 155.76 ± 9.05 ㎍/㎖ 이상이다. In addition, the polyphenol content of the black samreung outpost showing 50% or more active oxygen species inhibition activity was calculated as mg content (mg GAE / 100g dw) per 100g of dry sample using the calibration curve by gallic acid. ± 13.57mg GAE / 100g dw and flavonoid content is 61.01 ± 3.62 mg rutin / 100g dw or more calculated as mg content per 100g of dry sample (mg RE / 100g dw) using calibration curve by rutin , The content of Black Samreung Outpost extract showing 50% DPPH radical scavenging activity is 166.30 ± 5.94 μg / ml or more, and the content of Black Samneung Outpost extract showing 50% ABTS radical scavenging activity is 155.76 ± 9.05 μg / ml or more.
이 때, 흑삼릉 전초 추출물 1㎎/㎖은 60.29±4.12%의 치주질환 염증에 의해 생성되는 아질산염(nitrite) 소거활성을 나타낸다. At this time, 1 mg / ㎖ of black samreung outpost extract exhibits nitrite scavenging activity produced by inflammation of the periodontal disease of 60.29 ± 4.12%.
또한, 50% 이상의 활성 산소종 억제 활성을 나타내는 감태나무의 줄기 또는 잎의 폴리페놀 함량이, 갈산(gallic acid)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg GAE/100g dw)으로 계산할 때, 189.70 ± 4.33 mg GAE/100g 이고, 플라보노이드 함량이 루틴(rutin)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg RE/100g dw)으로 계산하면 67.50 ± 1.45 mg RE/100g dw 이상 일때, 50%의 DPPH 라디칼 소거 활성을 나타내는 감태나무 줄기 또는 잎의 추출물 함량은 28.45 ± 3.96 ㎍/㎖ 이상이며, 50%의 ABTS 라디칼 소거 활성을 나타내는 감태나무의 줄기 또는 잎의 추출물의 함량은 34.52±0.34 ㎍/㎖ 이상이다.In addition, the polyphenol content of the stem or leaves of E. coli showing 50% or more active oxygen species inhibition activity was obtained in mg content (mg GAE / 100g dw) per 100g of dry sample using the calibration curve by gallic acid. When calculated, it is 189.70 ± 4.33 mg GAE / 100g, and the flavonoid content is 67.50 ± 1.45 mg RE / 100g dw when the mg content per 100g of dry sample (mg RE / 100g dw) is calculated using the calibration curve by rutin. In this case , the extract content of E. coli stem or leaf exhibiting 50% DPPH radical scavenging activity is 28.45 ± 3.96 μg / ml or more, and the extract content of stem or leaf of E. coli showing 50% ABTS radical scavenging activity 34.52 ± 0.34 μg / ml or more.
이 때, 감태나무 줄기 및 잎의 추출물 1㎎/㎖은 67.64±7.06%의 치주질환 염증에 의해 생성되는 아질산염(nitrite) 소거활성을 나타낸다. At this time, 1 mg / ml of the extract of E. coli stem and leaf exhibits nitrite scavenging activity produced by inflammation of periodontal disease of 67.64 ± 7.06%.
본 발명에 따른 천연 추출물은, 상기한 천연물 소재를 물 또는 알코올에 넣고 가열하여 추출물을 얻고, 상기 추출물을 농축함으로써 제조될 수 있다. The natural extract according to the present invention can be prepared by heating the natural material described above in water or alcohol to obtain an extract and concentrating the extract.
예를 들어, 건조된 상기 측백나무의 천연물 소재 150g 정도를 추출병에 넣고 증류수를 부어 80 ~ 121℃의 온도로 5시간 3회 정도 추출하거나, 또는 건조 천연물 소재 150g을 95 ~ 99% 농도의 에탄올 또는 메탄올에 1 ~ 15배의 부피량으로 넣고 냉각콘덴서가 부착된 추출기에서 70 ~ 80℃로 12시간 정도 가열하여 추출한 추출액을 다시 감압 여과한 후, 고형분을 제거하고 여액을 냉각콘덴서가 달린 농축장치에서 바람직하게는 50 ~ 90 brix로 감압 농축한 후 동결 건조시킴으로써 제조될 수 있다.  For example, 150 g of dried natural cypress material is put into an extraction bottle and poured distilled water and extracted three times at a temperature of 80 to 121 ° C. for 5 hours, or 150 g of dried natural material is 95 to 99% ethanol. Alternatively, the mixture is heated in methanol at a volume of 1 to 15 times and heated at 70 to 80 ° C. for 12 hours in an extractor equipped with a cooling capacitor. The extracted extract is filtered under reduced pressure, and the solids are removed and the filtrate is concentrated with a cooling capacitor. Preferred in the present invention may be prepared by concentrating under reduced pressure to 50 to 90 brix and then freeze drying.
상기한 천연 추출물은 구강질환 예방 및 치료제의 유효성분으로서, 제형에 관계없이 의약품으로 사용될 수 있고, 비제한적인 예로서, 액상치약, 구강청정제, 구강용 스프레이, 구강용 연고제, 구강용 바니쉬 등의 형태로 사용될 수 있다. The natural extract is an active ingredient for preventing and treating oral diseases, and can be used as a medicine regardless of the dosage form, and non-limiting examples include liquid toothpaste, mouthwash, mouth spray, oral ointment, oral varnish, and the like. It can be used in the form.
도 1은 본 발명의 실시예에 따라 추출된 측백나무, 흑삼릉, 감태나무 추출물의 스트렙토코쿠스 뮤탄스(Streptococcus mutans)의 50% 생장억제 활성농도 결정을 보여주는 그래프이다.1 is a graph showing 50% growth inhibitory activity concentration determination of Streptococcus mutans of the extracts of the cedar, black samreung, and persimmon tree extracted according to the embodiment of the present invention.
이하에서는 실시예 등을 참조하여 본 발명을 더욱 상술하지만, 본 발명의 범주가 그것에 의해 한정되는 것은 아니다. Hereinafter, the present invention will be further described with reference to Examples and the like, but the scope of the present invention is not limited thereto.
<실시예 1><Example 1>
건조된 측백나무, 흑삼릉, 감태나무의 천연물 소재 150g을 추출병에 넣고 증류수를 부어 90℃의 온도로 5시간 3회 추출하였다. 추출액은 다시 워터만 종이 여과지로 감압 여과한 후, 고형분은 제거하고 나머지 액을 냉각콘덴서가 달린 농축장치에서 감압 농축하여 동결 건조하였다(90 brix).  150g of dried natural materials of dried cedar, black samreung and persimmon trees were placed in an extraction bottle, and distilled water was poured and extracted three times at a temperature of 90 ° C. The extract was again filtered under reduced pressure with a waterman paper filter paper, solids were removed, and the remaining solution was concentrated under reduced pressure in a condenser equipped with a cooling capacitor and freeze-dried (90 brix).
<실험예 1>Experimental Example 1
상기 실시예 1에서 제조된 천연추출물을 이용하여 충치질환 유발세균의 생육저지 활성, 충치질환 유발세균에 대한 생장억제 활성농도를 결정하기 위한 실험을 진행하였다. 효능판정은 50%이상의 생장억제 효능을 나타내는 농도를 최소 농도로 판정하였다. 이는 예방 및 치료목적으로 사용되기 위한 세균의 최소 생장억제 활성 농도이다. Using the natural extract prepared in Example 1 was carried out experiments to determine the growth inhibition activity of the caries disease-causing bacteria, growth inhibitory activity concentration for the caries disease-causing bacteria. Efficacy determination was determined as the minimum concentration concentration showing a growth inhibitory effect of more than 50%. This is the minimum growth inhibitory activity concentration of bacteria for use in prophylactic and therapeutic purposes.
실험 세균으로서 구강질환 유발균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans)는 KCTC(Korean Collection for Type Cultures)에서 동결 바이알(vial)로 분양 받은 Streptococcus mutans KCTC3065를 사용하였다.  Streptococcus mutans, an oral disease-causing bacterium, as an experimental bacterium(Streptococcus mutans)Was sold as a frozen vial from the Korean Collection for Type Cultures (KCTC)Streptococcus mutans KCTC3065 was used.
스트렙토코쿠스 뮤탄스(Streptococcus mutans)는 뇌심장침출액(brain heart infusion)배지(Sheep brain and heart extract 37%)에 접종하여 37℃, 호기성 조건으로 20~24시간 배양하였다. 각각의 천연물의 구강질환 유발세균에 대한 50% 생장억제 활성농도(㎍/㎖)을 결정하기 위해 각각 천연추출물을 액체 배지에 첨가, 연속희석방법(serial dilution method)을 통해 0~500㎍/㎖ 농도의 범위로 희석하여 멸균하였다. 또한, 각각의 천연 추출물의 농도별로 첨가된 배지에 전배양된 각각의 세균을 분광광도계 OD600nm에서 2 × 106 cell/㎖가 되도록 접종하여 각 균의 성장조건에서 배양하였다. 배양 후 분광광도계를 이용하여 접종 시와 배양 종료후의 OD600nm에서 흡광도를 측정하여 50% 생장억제 활성농도값(㎍/㎖)을 측정하였다. 그 결과를 하기 표 1에 표시하였다. Streptococcus mutans was inoculated in brain heart infusion medium (Sheep brain and heart extract 37%) and incubated for 20 to 24 hours at 37 ℃, aerobic conditions. To determine the 50% growth inhibitory activity concentration (µg / ml) of each natural oral disease-inducing bacterium, natural extracts were added to the liquid medium, and 0 to 500 µg / ml through the serial dilution method. Diluted to a range of concentrations and sterilized. In addition, each of the bacteria pre-cultured in the medium added by the concentration of each natural extract was inoculated to 2 × 10 6 cells / ㎖ in the spectrophotometer OD 600nm and incubated under the growth conditions of each bacteria. After cultivation, the absorbance was measured at OD 600 nm at the time of inoculation and at the end of incubation using a spectrophotometer to measure 50% growth inhibitory activity concentration value (µg / ml). The results are shown in Table 1 below.
표 1
Figure PCTKR2013000530-appb-T000001
Table 1
Figure PCTKR2013000530-appb-T000001
상기 표 1에서 보는 바와 같이, 본 발명에 따른 각각의 추출물의 100 ~ 500 ㎍/㎖의 농도를 첨가하였을 경우, 구강질환 유발 세균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans)의 생장이 억제됨을 알 수 있다. 실험에 사용한 시료가 완전히 정제되지 않은 추출물로 낮은 성장 저해 활성을 나타내었지만 정제 할 경우 이보다 낮은 농도에서 성장 저해 활성을 나타낼 것으로 예측된다. 이는 구강 위생 제품 생산 시, 낮은 농도에서도 구강질환 유발 세균의 생장을 억제함으로 적은 양을 첨가하더라도 효과적으로 구강질환 예방 및 치료 효과를 발휘할 수 있음을 의미한다.As shown in Table 1, when the concentration of 100 ~ 500 ㎍ / ㎖ of each extract according to the present invention, it can be seen that the growth of Streptococcus mutans , oral disease-causing bacteria have. The sample used in the experiment showed low growth inhibitory activity as an extract that was not completely purified, but it would be expected to show growth inhibitory activity at lower concentrations when purified. This means that in the production of oral hygiene products, even at low concentrations, it suppresses the growth of oral disease-causing bacteria, and thus even if a small amount is added, it can effectively prevent or treat oral diseases.
실험 결과는 3회 반복 측정 후 시료군 간의 유의성을 검증하였다. 다만, 상기와 같이 얻어진 각 천연물소재의 추출물은 식물의 채취 시기, 서식 장소 등 식물의 성장 환경에 따라 효능 함량이 달라 질 수도 있다. The experimental results verified the significance between sample groups after three repeated measurements. However, the extract of each natural material obtained as described above may vary in efficacy depending on the growth environment of the plant, such as when the plant is collected, the place of habitation.
<실험예 2> 총 폴리페놀 함량 및 총 플라보노이드 함량 측정Experimental Example 2 Measurement of Total Polyphenol Content and Total Flavonoid Content
실시예 1에서 제조된 천연추출물을 이용하여 총 폴리페놀 함량 및 총 플라보노이드 함량을 측정하였다. Total polyphenol content and total flavonoid content were measured using the natural extract prepared in Example 1.
폴리페놀은 항산화 효과가 있어 식품이나 의료 등에 응용되는 주요 물질로서 알려져 있다. 본 발명에 따른 천연 추출물 1 ㎎/㎖ 100 ㎕에 10% Na2CO3 100㎕를 첨가한 후 상온에서 5분간 정치(定置)하였다.Polyphenols have an antioxidant effect and are known as major substances applied to foods and medicine. 100 μl of 10% Na 2 CO 3 was added to 100 μl of the natural extract 1 mg / ml according to the present invention and allowed to stand at room temperature for 5 minutes.
상기 추출물 혼합액과 50% Folin-Ciocalteu 시약(Folin-ciocalteau's phenol reagent) 100 ㎕을 혼합하여 반응시키고 상온조건의 암실에서 60분간 보관한 후 분광광도계를 이용하여 725 nm에서 흡광도를 측정하였다. 갈산(gallic acid)를 0 ~ 1,000 ㎎/㎖의 농도로 제조하여 시료와 동일한 방법으로 분석하여 얻은 표준 검량선으로부터 시료추출물의 총 페놀 함량을 계산하였다. 50% Folin-Ciocalteu with the extract mixture 100 μl of the reactant (Folin-ciocalteau's phenol reagent) was mixed and reacted, and stored in a dark room at room temperature for 60 minutes, and then absorbance was measured at 725 nm using a spectrophotometer. The total phenol content of the sample extract was calculated from the standard calibration curve obtained by preparing gallic acid at a concentration of 0 to 1,000 mg / mL and analyzing the same method as the sample.
모레노(Moreno) 방법(Ref. Nieva Moreno 2000)에 따라 천연 추출물 1 ㎎/㎖ 100㎕에 10% 염화 알루미늄(aluminum chloride) 100㎕를 첨가한 후 상온에서 5분간 정치한 후, 상기 추출물 혼합액과 1.0 M 초산 칼륨(potassium acetate) 100㎕을 혼합하여 반응시키고 상온조건에서 40분간 보관한 후 분광광도계를 이용하여 420 nm에서 흡광도를 측정하였다. Rutin을 표준물질로 하여 0 ~ 1,000 ㎎/㎖의 농도범위에서 얻어진 표준 검량선으로부터 추출물의 총 플라보노이드 함량을 계산하였다. According to Moreno method (Ref. Nieva Moreno 2000), 100 μl of 10% aluminum chloride was added to 100 μl of natural extract 1 mg / ml, and then allowed to stand at room temperature for 5 minutes. After reacting by mixing 100 μl M acetate (potassium acetate) and storing at room temperature for 40 minutes, the absorbance was measured at 420 nm using a spectrophotometer. The total flavonoid content of the extract was calculated from the standard calibration curve obtained at a concentration range of 0 to 1,000 mg / ml using Rutin as a standard.
성분의 함량은 식품의약안정청의 권고 사안에 따라 표준 시료인 갈산(gallic acid)와 루틴(rutin)으로부터 작성된 검량 곡선을 이용하여 건조시료 100g당 mg함량으로 표시하였다. 그 결과를 하기 표 2에 나타내었다. The content of the ingredient was expressed in mg content per 100g of dry sample using calibration curves prepared from gallic acid and rutin, which are standard samples according to the recommendations of the Food and Drug Administration. The results are shown in Table 2 below.
표 2
Figure PCTKR2013000530-appb-T000002
TABLE 2
Figure PCTKR2013000530-appb-T000002
상기 표 2에서 보는 바와 같이, 본 발명에 따른 추출물의 총 폴리페놀과 총 플라보노이드의 함량은 측백나무에서 가장 많은 함유량을 갖는 것으로 확인되었다. 항산화 소재로서 측백나무 추출물이 흑삼릉 추출물, 감태나무 추출물보다 바람직함을 확인할 수 있었다. As shown in Table 2, the total polyphenol and total flavonoid content of the extract according to the present invention was confirmed to have the highest content in the cypress. As an antioxidant, it was found that the cypress extract is more preferable than the black samreung extract and the persimmon tree extract.
실험 결과는 3회 반복 측정 후 평균±표준편차로 나타내었으며, 시료군 간의 유의성을 검증한 후 p<0.05 수준에서 던칸(Duncan)의 다중범위 검증법(multiple range test)에 따라 분석하였다. 다만, 상기와 같이 얻어진 각 천연물소재의 추출물은 식물의 채취 시기, 서식 장소 등 식물의 성장 환경에 따라 효능 함량이 달라 질 수도 있다. The experimental results were expressed as mean ± standard deviation after three repeated measurements. The significance between the sample groups was verified and analyzed according to Duncan's multiple range test at p <0.05. However, the extract of each natural material obtained as described above may vary in efficacy depending on the growth environment of the plant, such as when the plant is collected, the place of habitation.
<실험예 3> DPPH 라디칼 소거능 및 ABTS 라디칼을 이용한 총 항산화력 측정Experimental Example 3 Measurement of Total Antioxidant Capacity Using DPPH Radical Scavenging Capacity and ABTS Radical
실시예 1에서 제조된 천연추출물을 이용하여, 활성 산소종의 활성 저해 효능 확인을 위한 자유라디칼 소거 활성측정을 위해 DPPH 항산화 활성 테스트와 ABTS 항산화 활성 테스트를 수행하였다. Using the natural extract prepared in Example 1, DPPH antioxidant activity test and ABTS antioxidant activity test were performed to determine the free radical scavenging activity to determine the inhibitory effect of active oxygen species.
DPPH 라디칼 소거능 측정은 0.2 mM DPPH(2,2-diphenyl-2-picrylhydrazyl hydrate) 60㎕와 농도별로 준비한 시료 60㎕를 혼합하여 상온의 암실에서 15~30분간 반응시킨 후 분광광도계를 이용하여 517 nm에서 흡광도를 측정하였다. DPPH radical scavenging activity was measured by mixing 60 μl of 0.2 mM DPPH (2,2-diphenyl-2-picrylhydrazyl hydrate) and 60 μl of the sample prepared for each concentration, and reacting in a dark room at room temperature for 15 to 30 minutes using a spectrophotometer. Absorbance was measured at.
ABTS 라디칼을 이용한 총 항산화력 측정은 과항산 칼륨(potassium persulfate)와의 반응에 의해 생성된 ABTS(2,2`-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) 유리 라디칼이 추출물 내의 항산화 물질에 의해 제거되어 라디칼 특유의 색인 청록색을 탈색시키는 방법으로 수행되었다. Total antioxidant activity using ABTS radicals was determined by the ABTS (2,2`-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) free radicals produced by reaction with potassium persulfate. Removed to decolorize the radical cyan.
7.4 mM ABTS와 2.6 mM potassium persulfate를 동량 혼합하여 암실에서 15~24시간 반응시킨다. 사용직전에 734 nm에서 흡광도 0.7(±0.03)로 증류수를 이용하여 희석한다. 희석액 950㎕에 50㎕ 시료를 첨가하여 혼합한 다음, 실온에서 10분간 반응시킨 후 734 nm에서 흡광도를 측정하였다. DPPH 테스트의 항산화 활성의 정도는 50% DPPH 라디칼 소거활성 농도인 SC50 값으로 표시하고, ABTS 테스트의 항산화 활성의 정도는 50% ABTS 라디칼 소거활성 농도인 SC50 값으로 표시하였다. 대조군으로 사용된 갈산(gallic acid)의 DPPH SC50 값은 9.07 ± 0.2 ㎍/㎖로 측정되었으며, ABTS SC50 값은 4.96 ± 0.28 ㎍/㎖로 측정되었다.Equivalently mix 7.4 mM ABTS and 2.6 mM potassium persulfate and react for 15 to 24 hours in the dark. Immediately before use, dilute with distilled water to absorbance 0.7 (± 0.03) at 734 nm. 50 μl of the sample was added to 950 μl of the diluent, mixed, and then reacted at room temperature for 10 minutes, and the absorbance was measured at 734 nm. The degree of antioxidant activity in the DPPH test is degree of antioxidant activity of a display and, ABTS test the 50% DPPH radical scavenging activity concentration of SC 50 values are expressed as 50% ABTS radical scavenging activity concentration of 50 SC value. The DPPH SC 50 value of gallic acid used as a control was measured to be 9.07 ± 0.2 μg / ml and the ABTS SC 50 value was 4.96 ± 0.28 μg / ml.
또한, 치주질환 염증 치료 효과를 확인하기 위해 항산화 소재로서의 활용 가능성을 보이는 천연 추출물의 아질산염 소거능 테스트를 수행하였다.  In addition, the nitrite scavenging ability test of the natural extract showing the possibility of use as an antioxidant material to confirm the treatment effect of periodontal disease inflammation was performed.
아질산염(nitrite) 소거 활성은 카토(Kato)등의 방법(Ref. Kato H, Lee IE 1987)으로 수행 하였다. 1 mM NaNO2 40㎕에 천연물 추출물 40㎕를 첨가한다. 0.1 N HCl을 이용하여 pH 1.2로 보정한 후 37℃에서 1시간 반응시킨다. 2% acetic acid 1㎖와 Griess 시약 100 ㎕을 첨가한 후 상온에서 15분간 반응시킨 뒤 520 nm에서 흡광도를 측정하였다. 그 결과를 하기 표 3에 나타내었다. 치주질환 염증에 의해 생성되는 아질산염(nitrite) 소거활성의 대조군으로 vitamin C(ascorbic acid) 1㎎/㎖을 이용하였고, 대조군인 vitamin C의 소거 활성은 96.64±0.26%로 확인 되었다.Nitrite scavenging activity was performed by Kato et al. (Ref. Kato H, Lee IE 1987). 40 μl of 1 mM NaNO 2 is added to 40 μl natural extract. After calibrating to pH 1.2 using 0.1 N HCl, the reaction was carried out at 37 ° C. for 1 hour. After adding 1 ml of 2% acetic acid and 100 μl of Griess reagent, the reaction was performed at room temperature for 15 minutes and the absorbance was measured at 520 nm. The results are shown in Table 3 below. 1 mg / ml of vitamin C (ascorbic acid) was used as a control of nitrite scavenging activity produced by periodontal disease inflammation, and the scavenging activity of the control group, vitamin C, was 96.64 ± 0.26%.
표 3
Figure PCTKR2013000530-appb-T000003
TABLE 3
Figure PCTKR2013000530-appb-T000003
상기 표 3에서 보는 바와 같이, 본 발명에 따른 DPPH와 ABTS를 이용한 항산화 효능 측정 실험에서 측백나무와 감태나무에서 우수한 항산화 효능을 확인 할 수 있었으며, 아질산염 소거 활성은 측백나무가 우수하였다. As shown in Table 3, the antioxidant efficacy measurement experiment using the DPPH and ABTS according to the present invention was able to confirm the excellent antioxidant effect in the cypress and Ecklonia cava, the nitrite scavenging activity was excellent in the cypress.
상기 표 2 및 3에서 보는 바와 같이, 본 발명에 따른 천연물 소재인 측백나무, 흑삼릉 및 감태나무로 이루어진 군에서 선택하여 사용한 추출물은 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 50% 생장억제 활성을 나타내는 동시에 50%의 활성 산소종 억제 활성을 나타내었으며, 특히 측백나무가 바람직한 항산화 효능을 나타내었다.As shown in Tables 2 and 3, the extract used in the group consisting of the natural product of the natural material according to the present invention, the cedar, black samreung and persimmon tree is 50% growth inhibitory activity against Streptococcus mutans (Streptococcus mutans) At the same time, it exhibited 50% of active oxygen species inhibitory activity, in particular, the cypress had a desirable antioxidant effect.
실험 결과는 3회 반복 측정 후 평균±표준편차로 나타내었으며, 시료군 간의 유의성을 검증한 후 p<0.05 수준에서 던칸(Duncan)의 다중범위 검증법(multiple range test)에 따라 분석하였다. The experimental results were expressed as mean ± standard deviation after three repeated measurements. The significance between the sample groups was verified and analyzed according to Duncan's multiple range test at p <0.05.
본 발명이 속한 분야에서 통상의 지식을 가진 자라면 상기 내용을 바탕으로 본 발명의 범주 내에서 다양한 응용 및 변형을 행하는 것이 가능할 것이다. Those skilled in the art to which the present invention pertains will be able to perform various applications and modifications within the scope of the present invention based on the above contents.
이상의 설명과 같이, 본 발명에 따른 천연 추출물은 소정 농도에서 구강질환 유발균주인 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 50% 이상의 생장억제 활성과 50% 이상의 활성 산소종 억제 활성을 동시에 나타내므로, 이를 유효성분으로 포함하는 의약품은 치아우식증 및 치주질환을 동시에 예방 및 치료할 수 있는 장점이 있다.As described above, since the natural extract according to the present invention simultaneously exhibits at least 50% growth inhibitory activity and at least 50% active oxygen species inhibitory activity against Streptococcus mutans , an oral disease causing strain at a predetermined concentration. In addition, medicines containing this as an active ingredient have the advantage of preventing and treating dental caries and periodontal disease at the same time.
특히, 본 발명에 따른 천연 추출물을 치약, 구강청정제 등으로 사용하는 경우, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)의 생장을 50% 이상의 억제되어, 세균침전물인 치태를 효율적으로 제거할 수 있는 장점이 있다.In particular, when the natural extract according to the present invention is used as a toothpaste, oral cleaning agent, etc., the growth of Streptococcus mutans is suppressed by 50% or more, which has the advantage of efficiently removing plaque that is a bacterial precipitate. have.
또한, 상기 의약품 등은 안전성이 입증된 천연추출물을 유효성분으로 사용하므로, 부작용이 극히 적은 장점이 있다. In addition, the drug and the like because it is used as an active ingredient natural extract has been proven safe, there are very few side effects.

Claims (13)

  1. 천연물 소재로부터 분리한 구강질환 예방 및 치료용 활성을 가진 추출물로서, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 50% 이상의 생장억제 활성과 50% 이상의 활성 산소종 억제 활성을 동시에 나타내는 것을 특징으로 하는 천연 추출물. Streptococcus mutans with extracts for the prevention and treatment of oral diseases isolated from natural products(Streptococcus mutans)50% or more growth inhibition and 50% activity against Natural extract, characterized in that simultaneously showing oxygen species inhibitory activity.
  2. 제 1 항에 있어서, 상기 천연 추출물은 측백나무, 흑삼릉 및 감태나무로 이루어진 군에서 선택되는 천연물 소재로부터 분리되는 것을 특징으로 하는 천연 추출물. According to claim 1, The natural extract is a natural extract, characterized in that separated from the natural material selected from the group consisting of cypress, black samreung and persimmon.
  3. 제 2 항에 있어서, 상기 천연 추출물은, 천연물 소재를 물 또는 알코올에 넣고 가열하여 추출물을 얻고, 상기 추출물을 농축하여 제조되는 것을 특징으로 하는 천연 추출물. The natural extract of claim 2, wherein the natural extract is prepared by heating a natural product into water or alcohol to obtain an extract, and concentrating the extract.
  4. 제 1 항에 있어서, 상기 천연물 소재는 측백나무의 잎, 열매 또는 줄기이고, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 50% 이상의 생장억제 활성을 위해 추출물의 함량이 500 ㎍/㎖ 이상인 것을 특징으로 하는 천연 추출물.The method of claim 1, wherein the natural material is a leaf, fruit or stem of the cypress, the extract content of 500 ㎍ / ㎖ or more for 50% growth inhibition activity against Streptococcus mutans (Streptococcus mutans) Natural extract.
  5. 제 1 항에 있어서, 상기 천연물 소재는 흑삼릉 전초나 감태나무의 줄기 또는 잎이고, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 50% 이상의 생장억제 활성을 위해 추출물의 함량이 100 ㎍/㎖ 이상인 것을 특징으로 하는 천연 추출물.The method according to claim 1, wherein the natural material is the stem or leaves of the black samreung outpost or the Ego tree, the extract content of more than 100 ㎍ / ㎖ for growth inhibition activity of 50% or more against Streptococcus mutans (Streptococcus mutans) Characterized in natural extracts.
  6. 제 1 항에 있어서, 상기 천연물 소재는 측백나무의 잎, 열매 또는 줄기의 폴리페놀 함량이, 갈산(gallic acid)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg GAE/100g dw)으로 계산할 때, 395.27±24.39 mg GAE/100g dw 이고, 플라보노이드 함량은 루틴(rutin)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg RE/100g dw)으로 계산하면 250.14±18.26 mg rutin/100g dw 일때, 50%의 DPPH(2,2-diphenyl-2-picrylhydrazyl hydrate) 라디칼 소거 활성을 나타내는 추출물의 함량이 33.10 ± 3.67 ㎍/㎖ 이상이며, 50%의 ABTS(2,2`-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) 라디칼 소거 활성을 나타내는 측백나무의 잎, 열매 또는 줄기 추출물의 함량은 62.96±5.23 ㎍/㎖ 이상인 것을 특징으로 하는 천연 추출물.The method of claim 1, wherein the natural material is a polyphenol content of the leaves, berries or stems of the cypress, mg content (mg GAE / 100g dw) per 100g dry sample using a calibration curve by gallic acid (gallic acid) When calculated, it is 395.27 ± 24.39 mg GAE / 100g dw and the flavonoid content is 250.14 ± 18.26 mg rutin / 100g when calculated as mg content per 100g dry sample (mg RE / 100g dw) using the calibration curve by rutin. In the case of dw , the extract showing 50% DPPH (2,2-diphenyl-2-picrylhydrazyl hydrate) radical scavenging activity was 33.10 ± 3.67 ㎍ / ml or more, and 50% ABTS (2,2`-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) A natural extract, characterized in that the content of the leaf, fruit or stem extract of the cypress showing radical scavenging activity is 62.96 ± 5.23 μg / ml or more.
  7. 제 1 항에 있어서, 상기 천연물 소재는 흑삼릉 전초의 폴리페놀 함량이, 갈산(gallic acid)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg GAE/100g dw)으로 계산할 때, 151.62±13.57mg GAE/100g dw 이고, 플라보노이드 함량이, 루틴(rutin)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg RE/100g dw)으로 계산하면 61.01±3.62 mg rutin/100g dw 이상일때, 50%의 DPPH(2,2-diphenyl-2-picrylhydrazyl hydrate) 라디칼 소거 활성을 나타내는 추출물의 함량이 166.30 ± 5.94 ㎍/㎖ 이상이며, ABTS 라디칼 소거 활성을 나타내는 흑삼릉 전초 추출물의 함량은 155.76 ± 9.05 ㎍/㎖ 이상인 것을 특징으로 하는 천연 추출물. The method of claim 1, wherein the natural material is 151.62 ± 13.57 when the polyphenol content of the black samreung outpost is calculated by the mg content per 100g dry sample (mg GAE / 100g dw) using a calibration curve by gallic acid (gallic acid) mg GAE / 100g dw and flavonoid content is calculated as mg content per 100g of dry sample (mg RE / 100g dw) using calibration curve by rutin, 50 or more 61.01 ± 3.62 mg rutin / 100g dw The content of the extract showing DPPH (2,2-diphenyl-2-picrylhydrazyl hydrate) radical scavenging activity of% was 166.30 ± 5.94 ㎍ / ml or more, and the content of the black tomb extract was 155.76 ± 9.05 ㎍ / Natural extract, characterized in that more than ml.
  8. 제 1 항에 있어서, 상기 천연물 소재는 감태나무의 줄기 또는 잎의 폴리페놀 함량이, 갈산(gallic acid)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg GAE/100g dw)으로 계산할 때, 189.70±4.33mg GAE/100g 이고, 플라보노이드 함량은 루틴(rutin)에 의한 검량곡선을 이용하여 건조시료 100g 당 mg 함량(mg RE/100g dw)으로 계산하면 67.50±1.45mg RE/100g dw 일때, 50%의 DPPH(2,2-diphenyl-2-picrylhydrazyl hydrate) 라디칼 소거 활성을 나타내는 추출물의 함량이 28.45 ± 3.96 ㎍/㎖ 이상이며, 50%의 ABTS 라디칼 소거 활성을 나타내는 감태나무의 줄기 또는 잎의 추출물의 함량은 34.52±0.34 ㎍/㎖ 이상인 것을 특징으로 하는 천연 추출물. The method of claim 1, wherein the natural material is the polyphenol content of the stem or leaves of Ecklonia cava, calculated as mg content (mg GAE / 100g dw) per 100g dry sample using a calibration curve by gallic acid (gallic acid) , 189.70 ± 4.33mg GAE / 100g, and the flavonoid content is 67.50 ± 1.45mg RE / 100g dw when calculated as mg content (mg RE / 100g dw) per 100g of dry sample using the calibration curve by rutin. An extract having a 50% DPPH (2,2-diphenyl-2-picrylhydrazyl hydrate) radical scavenging activity of 28.45 ± 3.96 μg / ml or more and having a 50% ABTS radical scavenging activity. Natural extract, characterized in that the content of the extract is 34.52 ± 0.34 ㎍ / ㎖ or more.
  9. 제 1 항에 있어서, 상기 천연물 소재는 측백나무의 잎, 열매 또는 줄기이고, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 50% 이상의 생장억제 활성과 50% 항산화 활성을 동시에 갖기 위한 추출물의 함량이 500 ㎍/㎖ 이상인 것을 특징으로 하는 천연 추출물.The method of claim 1, wherein the natural material is a leaf, fruit or stem of the cypress, the content of the extract for simultaneously having at least 50% growth inhibitory activity and 50% antioxidant activity against Streptococcus mutans (Steptococcus mutans) Natural extract, characterized in that more than 500 ㎍ / ㎖.
  10. 제 1 항에 있어서, 상기 천연물 소재는 흑삼릉 전초의 줄기 또는 잎이고, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 50% 이상의 생장억제 활성과 50% 항산화 활성을 동시에 갖기 위한 추출물의 함량이 160 ㎍/㎖ 이상인 것을 특징으로 하는 천연 추출물.The method of claim 1, wherein the natural material is the stem or leaves of the black samreung outpost, 160 ㎍ content of the extract to have at least 50% growth inhibitory activity and 50% antioxidant activity against Streptococcus mutans (Streptococcus mutans) Natural extract, characterized in that more than / ml.
  11. 제 1 항에 있어서, 상기 천연물 소재는 감태나무의 줄기 또는 잎이고, 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 50% 이상의 생장억제 활성과 50% 항산화 활성을 동시에 갖기 위한 추출물의 함량이 100 ㎍/㎖ 이상인 것을 특징으로 하는 천연 추출물.The method of claim 1, wherein the natural material is the stem or leaves of Ecklonia chinensis, the content of the extract for having at least 50% growth inhibitory activity and 50% antioxidant activity against Streptococcus mutans at the same time Natural extract, characterized in that more than / ml.
  12. 제 1 항 내지 제 11 항 중 어느 하나에 따른 천연 추출물을 포함하는 것을 특징으로 하는 약제 제형. A pharmaceutical formulation comprising a natural extract according to any one of claims 1 to 11.
  13. 제 12 항에 있어서, 상기 약제 제형은 액상치약, 구강청정제, 구강용 스프레이, 구강용 연고제 또는 구강 바니쉬인 것을 특징으로 하는 약제 제형. 13. The pharmaceutical formulation of claim 12, wherein the pharmaceutical formulation is a liquid toothpaste, a mouthwash, an oral spray, an oral ointment or an oral varnish.
PCT/KR2013/000530 2012-03-28 2013-01-23 Natural extract for preventing and treating oral disease WO2013147409A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2012-0031773 2012-03-28
KR1020120031773A KR20130109765A (en) 2012-03-28 2012-03-28 Herbal extract for preventing and treating disease of oral cavity

Publications (1)

Publication Number Publication Date
WO2013147409A1 true WO2013147409A1 (en) 2013-10-03

Family

ID=49260618

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/000530 WO2013147409A1 (en) 2012-03-28 2013-01-23 Natural extract for preventing and treating oral disease

Country Status (2)

Country Link
KR (1) KR20130109765A (en)
WO (1) WO2013147409A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107064324A (en) * 2016-12-06 2017-08-18 山东省中医药研究院 A kind of authentication method and content assaying method of the HPLC finger-prints of Rhizoma Sparganii polyphenol components
CN112326567A (en) * 2020-10-09 2021-02-05 天津科技大学 Optimized extraction method of pumpkin antioxidant active ingredients and verification method of antioxidant activity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100021260A (en) * 2008-08-14 2010-02-24 태림상사 (주) Improvement of antioxidant effect of ecklonia cava by far infrared radiation drying

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100021260A (en) * 2008-08-14 2010-02-24 태림상사 (주) Improvement of antioxidant effect of ecklonia cava by far infrared radiation drying

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAEK, DONG-HEON: "Screening of the Natural Plant Extracts for the Antimicrobial Activity on Dental Pathogens", THE KOREAN JOURNAL OF MICROBIOLOGY, vol. 43, no. 3, September 2007 (2007-09-01), pages 227 - 231 *
GAN, REN-YON ET AL.: "Antioxidant activity and total phenolic content of medicinal plants associated with prevention and treatment of cardiovascular and cerebrovascular diseases", JOURNAL OF MEDICINAL PLANTS RESEARCH, vol. 4, no. 22, 18 November 2010 (2010-11-18), pages 2438 - 2444 *
KIM, JI HOE ET AL.: "Antibacterial Activity of Sea-mustard, Laminaria Japonica Extracts on the Cariogenic Bacteria, Streptococcus mutans", J. KOREAN FISH. SOC., vol. 35, no. 2, 2002, pages 191 - 195 *
PARK, YUN-MI ET AL.: "Anticariogenic and Antioxidant Activities from Medicinal Herbs", J. KOREAN SOC. FOOD SCI. NUTR., vol. 35, no. 3, 2006, pages 284 - 293, XP053026418 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107064324A (en) * 2016-12-06 2017-08-18 山东省中医药研究院 A kind of authentication method and content assaying method of the HPLC finger-prints of Rhizoma Sparganii polyphenol components
CN107064324B (en) * 2016-12-06 2019-07-30 山东省中医药研究院 A kind of identification method and content assaying method of the HPLC finger-print of trigone polyphenol components
CN112326567A (en) * 2020-10-09 2021-02-05 天津科技大学 Optimized extraction method of pumpkin antioxidant active ingredients and verification method of antioxidant activity

Also Published As

Publication number Publication date
KR20130109765A (en) 2013-10-08

Similar Documents

Publication Publication Date Title
KR101233857B1 (en) Cosmetic composition with natural orientalplant extract
WO2018062605A1 (en) Toothpaste composition containing galenical extract
CN1832751B (en) Periodontal disease therapeutic and/or preventive composition
KR101452770B1 (en) Cosmetic composition comprising lactobacillus fermented solution having anti-oxidation, whitening and anti-wrinkle effect
KR101884660B1 (en) Cosmetic composition containing the enzymatic extracts of natural substances comprising propolis, royal jelly and honey
KR101483749B1 (en) Whitening cosmetic composition and Antibacterial composition containing the extract of Hippophae rhamnoides L.
CN110384725B (en) A Chinese medicinal composition for regulating oral flora and preparation method of active extract thereof
KR101930264B1 (en) Cosmetic composition for inhibiting secretion of sebum and for improving acne symptoms containing natural complex extract
KR100770140B1 (en) A Composition for Wet Tissue
WO2019225786A1 (en) Antibacterial and antifungal composition comprising extract from clove, hibiscus, and coconut as effective ingredient
WO2013147409A1 (en) Natural extract for preventing and treating oral disease
KR100820237B1 (en) A cosmetic composition comprising an extract of crude drug complex showing anti-oxidant and moisturizing activities
KR102162661B1 (en) Toothpaste Composition Comprising Rosa Canina Extract
KR101506858B1 (en) Herbal Extract for Having an Antibacterial and Antibiofilm Effect on Oral Pathogen
WO2019059572A2 (en) Novel antimicrobial peptide derived from skate skin and use thereof
KR101293418B1 (en) Fermented extract of Oriental medicine plant complex, method for manufacturing the same and cosmetic compositions comprising the oriental medicine plant complex
KR102594674B1 (en) Oral composition comprising herbal complex
KR101426238B1 (en) Herbal Extract For Preventing and Treating Disease of Oral Cavity
CN113332342A (en) Traditional Chinese medicine extract for resisting oral helicobacter pylori, oral care product and preparation method thereof
KR20220094308A (en) Pharmaceutical composition for preventing or treating infectious symptoms by pathogenic microorganism comprising Cichorium intybus extract as an active ingredient
KR20090046387A (en) Functional cosmetic composition comprising scutellaria,houttuynia,artemisia,citurs junos extract having antimicrobial activity
Jogdande et al. A review: honey for nutrition and health
WO2019039919A2 (en) Composition having inhibitory effect on virus and bacteria
WO2021241796A1 (en) Cosmetic composition and method for producing same
KR100776695B1 (en) Composition for treatment of atopic dermatitis including natural plant extract of azalca group

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13768903

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13768903

Country of ref document: EP

Kind code of ref document: A1